These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 6141237)
21. Analysis of Particulate Matter in Liquid-Finished Dosage Forms. Duchek J; Havasi B PDA J Pharm Sci Technol; 2018; 72(6):608-625. PubMed ID: 29853612 [TBL] [Abstract][Full Text] [Related]
22. Determination of particulate matter in intravenous solutions using the Coulter counter. Blaug SM; Sarabia RE Bull Parenter Drug Assoc; 1975; 29(2):74-88. PubMed ID: 1120215 [No Abstract] [Full Text] [Related]
23. Evaluation of acceptance criteria for particulate limits for small-volume parenteral products. Tsuji K; Lewis AR J Pharm Sci; 1978 Jan; 67(1):50-5. PubMed ID: 619115 [TBL] [Abstract][Full Text] [Related]
24. Effects of agitation on size distribution of particulate matter in large-volume parenterals. Blanchard J; Schwartz JA; Byrne DM J Pharm Sci; 1977 Jul; 66(7):935-8. PubMed ID: 886454 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of the Royco 367 small volume sample feeder for estimation of particulate contamination in ampoules [proceedings]. Davies PJ; Smart JD J Pharm Pharmacol; 1979 Dec; 31 Suppl():108P. PubMed ID: 42681 [No Abstract] [Full Text] [Related]
26. Particulate matter in four reconstituted cephalosporin injections. Kilarski DJ; Visconti JA; Frank SG Am J Hosp Pharm; 1983 Apr; 40(4):619-23. PubMed ID: 6846372 [TBL] [Abstract][Full Text] [Related]
27. Interlaboratory comparison about feasibility of insoluble particulate matter test for injections with reduced test volume in light obscuration method. Harazono A; Shibata H; Kiyoshi M; Muto T; Fukuda J; Torisu T; Saitoh S; Nishimura H; Uchiyama S; Ishii-Watabe A Biologicals; 2019 Jan; 57():46-49. PubMed ID: 30553568 [TBL] [Abstract][Full Text] [Related]
30. An assessment of techniques for evaluating the physical stability of parenteral emulsions. Zhang X; Kirsch LE PDA J Pharm Sci Technol; 2003; 57(4):300-15. PubMed ID: 14558703 [TBL] [Abstract][Full Text] [Related]
31. Approaches to reducing subvisible particle counts in lyophilized parenteral formulations. Gupta PK; Porembski E; Williams NA J Pharm Sci Technol; 1994; 48(1):30-7. PubMed ID: 8004415 [TBL] [Abstract][Full Text] [Related]
32. A new coincidence model for single particle counters, Part I: Theory and experimental verification. Knapp JZ; Abramson LR J Pharm Sci Technol; 1994; 48(3):110-34. PubMed ID: 8069513 [TBL] [Abstract][Full Text] [Related]
33. Specification of limits for particulate contamination in pharmaceutical dosage forms. Hailey DM; Lea AR; Kendall CE J Pharm Pharmacol; 1982 Oct; 34(10):615-20. PubMed ID: 6128382 [TBL] [Abstract][Full Text] [Related]
34. Particulate contamination of lyophilized amphotericin B preparation during reconstitution process. Sendo T; Hirakawa M; Makino K; Nakashima K; Kataoka Y; Oishi R J Clin Pharm Ther; 2001 Apr; 26(2):87-91. PubMed ID: 11350530 [TBL] [Abstract][Full Text] [Related]